Table 3: Univariate and Multivariable Cox Regression Analysis Cardiovascular Disease Mortality versus Independent Variables ( 𝑛 = 1 3 1 1 5 ).

Univariate analysisMultivariable analysis
OR95.0% C.I.Sig.OR95.0% C.I.Sig.

Race
 White (ref)1.001.00
 African american0.570.50–0.65 < .0010.830.71–0.98.02
 Hispanic & other0.420.36–0.48 < .0010.690.59–0.82 < .001
Gender (ref)
 Female1.001.00
 Male1.211.09–1.33 < .0011.401.23–1.59 < .001
Age (years)
< 64 (ref)1.001.00
 ≥653.423.20–3.70 < .0012.622.40–2.85 < .001
Poverty/income ratio
< 1 (ref)1.001.00
> 10.630.57–0.70 < .0010.730.64–0.83 < .001
Smoking status
 Never smoked (ref)1.001.00
 Ever-smoker (currently nonsmoker)1.231.10–1.37 < .0010.970.85–1.11N/S
 Current-smoker0.640.55–0.74 < .0011.070.89–1.28N/S
History of CVD (stroke, MI & congestive heart failure)
 No (ref)1.001.00
 Yes5.104.60–5.66 < .0012.402.11–2.72 < .001
Renal dysfunction & metabolic syndrome
 No metabolic syndrome and no renal dysfunction (ref)1.001.00
 No metabolic syndrome and early renal dysfunction3.022.45–3.72 < .0011.691.37–2.10 < .001
 No metabolic syndrome and late renal dysfunction15.3912.16–19.48 < .0013.923.06–5.03 < .001
 Metabolic syndrome and no renal dysfunction1.711.31–2.221.220.94–1.60
 Metabolic syndrome and early renal dysfunction4.143.36–5.09 < .0011.801.45–2.23 < .001
 Metabolic syndrome and late renal dysfunction12.8110.27–16.00 < .0013.232.56–3.70 < .001